NLRP3 Antibody (N-term) Blocking Peptide

Catalog Number: ABT-BP8564A
Article Name: NLRP3 Antibody (N-term) Blocking Peptide
Biozol Catalog Number: ABT-BP8564A
Supplier Catalog Number: BP8564a
Alternative Catalog Number: ABT-BP8564A-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: NACHT, LRR and PYD domains-containing protein 3, Angiotensin/vasopressin receptor AII/AVP-like, Caterpiller protein 11, CLR11, Cold autoinflammatory syndrome 1 protein, Cryopyrin, PYRIN-containing APAF1-like protein 1, NLRP3, C1orf7, CIAS1, NALP3, PYPAF1
NLRP3 is a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NALP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis.
NCBI: 114548
UniProt: Q96P20
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP8564a was selected from the N-term region of human NLRP3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.